ACG Engineering (ACGE), part of India-headquartered ACG group, has acquired Germany-based pharma processing equipment company Xertecs. The deal, which entails ACG acquiring 100% of the shares, follows a previous partnership between the two companies.

The Xertecs facility and team in Muellheim, Germany will become a key center of excellence to serve as ACG Innovation Centre Europe

Richard Stedman, group CEO, ACG Engineering, said: “This is a tremendous boost for our commitment to create next-generation machines that serve our pharmaceutical and nutraceutical customers. The Xertecs team brings best-in-class design and product management skills to ACG Engineering. We are looking forward to developing a wide range of innovative, ground-breaking equipment solutions and best-practice initiatives between the two teams.”

Klaus Groeschel, managing director, Sales & Marketing for Xertecs added: “This represents a great opportunity for ACG to meet global design standards throughout its product portfolio. This is the next logical step in the relationship between our two businesses. The team at Xertecs is very enthusiastic for the opportunity to continue contributing to ACG’s global product offerings and service capabilities.”

The German company develops and implements processes, products and services for pharma companies around the world. Its portfolio includes conceptualization; design engineering; prototype development; automation design and integration into MES systems; development and optimization of components; complete plant design including 3D modeling, and process optimization and delivery of new process equipment.